Cellino and Matricelf Partner for Global Expansion of Personalized Spinal Cord Injury Treatments Cellino and Matricelf (TASE: MTLF) have announced a new collaboration aimed at accelerating the global biomanufacturing of…
CareDx Expands AlloSure Testing Services with Two New Indications CareDx, Inc. (Nasdaq: CDNA), known as The Transplant Company™, a leader in precision medicine focused on the discovery, development, and commercialization…
RadiusXR, Glaukos, and Topcon Healthcare Launch Inspire® Visual Field Solution Topcon Healthcare, RadiusXR, and Glaukos Corporation (NYSE: GKOS) have announced a new collaboration, unveiling RadiusXR’s next-generation wearable vision testing platform,…
Robert Musslewhite and Sudhakar Ramakrishna Appointed to Cardinal Health Board of Directors Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert Musslewhite and Sudhakar Ramakrishna…
Care Access Acquires Brazil’s CEMEC Clinical Research Center Care Access, a global healthcare and research company, has announced the acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a leading clinical…
Ventus Therapeutics Doses First Patient in Phase 2a Trial of VENT-02 for Parkinson’s Disease Ventus Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapies for immunological, inflammatory, and…
Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Showing Sotyktu’s Superiority in Psoriatic Arthritis Bristol Myers Squibb (NYSE:BMY) today announced positive results from the pivotal Phase 3 POETYK PsA-2 trial…
Nimbus Therapeutics Appoints Abbas Kazimi CEO Nimbus Therapeutics, LLC, a biotechnology company focused on designing and developing breakthrough medicines through its advanced computational drug discovery platform, has announced the appointment…
Proteintech Unveils Next-Gen 3D Epitope Mapping to Boost Life Sciences Research Proteintech, a global leader in antibody and life science solutions, is proud to announce the launch of enhanced product…
Auna Signs Five-Year Deal to Enhance Oncology Services in Monterrey Auna S.A. (NYSE: AUNA), a leading Latin American healthcare company with operations in Mexico, Peru, and Colombia, has announced a…
Ventus Therapeutics Highlights Caspase-4/5 as Promising Therapeutic Targets in Nature Reviews Immunology Ventus Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapies for immunological, inflammatory, and neurological disorders,…
QIAGEN Gets U.S. Approval for Second QIAstat-Dx Mini GI Panel QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved the…